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Abstract
Aim: The occurrence of acute renal failure (ARF) cases continues to increase every year. Some of the cases are due to 
nephrotoxic effect caused by overdose of antibiotic consumption or abuse of the drug, gentamicin. An antibiotic therapy 
that can be used to overcome in such a case is the pomegranate extracts. However, until now, studies using pomegranate for 
cases of ARF have not been done. This study aims to determine changes in body weight, the levels of total protein (TP), and 
the levels of serum uric acid (UA) as a result of the pomegranate extract consumption.
Materials and Methods: A total number of 32 rats (Rattus norvegicus) were divided into four groups randomly. One 
group was assigned as the control group (P0) and given intraperitoneal (i.p.) saline and 0.3% carboxy methyl cellulose 
sodium (CMC) Na; P1 was provided with 80 mg/kg bw/i.p. gentamicin and 0.3% CMC Na orally, P2 was supplied with 
80 mg/kg bw/i.p. gentamicin and ellagic acid in 0.3% CMC Na, and P3 was given 80 mg/kg bw/i.p. gentamicin and 
150 mg/kg bw pomegranate extract in 0.3% CMC Na. The provision of treatment was carried out in 8 days and followed by 
making the overthrow of body weight and blood sampling for the examination of study variables.
Results: The results taken by doing the analysis of variance method for the four treatment groups show that the control 
group (P0) has significant differences from P1, P2, and P3 (p<0.05), but there are no significant differences among the 
other three treatment groups. Meanwhile, the average values of serum UA levels among P1, P2, and P3 indicate significant 
differences.
Conclusion: In conclusion, the administration of pomegranate extracts in the treatment of nephrotoxicity toward rats is 
effective to maintain normal body weight, normal TP levels, and the UA blood serum of the rats. As this study is a preventive 
therapy, it needs further researches about the effective dose as a curative therapy, its level of effectiveness and its long-term 
side effects.
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Introduction
Renal failure is the failure of kidneys to remove 
excess metabolites which are accumulated in the 
blood. It is a systemic disease and a final common 
pathway of various urinary tract and kidney dis-
eases [1]. It triggers electrolyte balance disorders, 
acid-base and water, renal failure. The failure is clas-
sified into acute renal failure (ARF) and chronic renal 
failure [2]. The ARF is characterized by the decrease 
of the urine volume and an increase of urea and creat-
inine values in 24 h [3]. The progressive weight loss, 
increased levels of uric acid (UA), and a decrease 
of total plasma protein are also major indications of 
patients with ARF.
The number of patients with kidney failure 
increases quite a lot and is predicted to continue every 
year. This is due to factors such as false dose of neph-
rotoxic drug consumption, lack of public awareness 
about the dangers of kidney disease and its preven-
tion which should be done from an early age, and so 
on [4]. Determining kidney damage can be carried 
out by checking physical parameters such as weight 
measurement and biochemical parameters such as the 
examination of the levels of urea, creatinine, UA and 
the total serum protein.
 Kidneys are bean-shaped organs that lie behind 
the peritoneum, on both sides of the vertebral column. 
The cross-section of the kidney is divided into two parts, 
namely, the cortex and the medulla in which the cortex 
is darker than the medulla [5]. The renal medulla is coni-
cal masses which are called renal pyramids [6]. The size 
of kidney in various species is primarily determined by 
the number of their nephrons [7]. The general structure 
of histological kidney can be shown in Figure-1.
Most potassium and UA is reabsorbed by a 
distal convoluted tubule and secreted into a distal 
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tubule. The formation of ammonia, the acidification 
of urine, and the water phase setting of the water and 
acid-base balance ensues in the distal convoluted 
tubules. The secretion and the selective reabsorption 
process are completed within the distal convoluted 
tubules and ductus collectivus [8]. Kidneys have a 
secretory function, one of which is to excrete end 
products of nitrogen and protein metabolism (espe-
cially urea, UA, and creatinine), foreign chemicals 
(such as pharmaceuticals), hormones, and other 
metabolites [9].
Pomegranate fruit is round with the skin colors of 
green, purple, white, reddish-brown, or purple-black. 
Its red or white seeds (which are very high in number) 
are small, slightly flattened, elliptical, and hard [10]. 
The characteristics of pomegranate can be shown in 
Figure-2.
One of the components of pomegranate is ellagic 
acid (EA), an ingredient that can protect cell damage 
which is caused by free radicals. This capability will 
synergistically increase when it is combined with 
another strong antioxidant composition of pomegran-
ate, anthocyanidins [10,12].
The degree of proteinuria and the composition 
of proteins in the urine depend on the mechanism of 
kidney injury resulting the loss of protein. A large 
number of proteins normally passes through the glo-
merular capillary but does not penetrate the urine. The 
glomerular wall’s substance and selectivity prevent 
the transport of albumin, globulin, and protein with 
other large molecular weight to penetrate its walls. If 
this barrier is broken, there is a plasma protein leakage 
in the urine (glomerular proteins). The smaller pro-
tein (<20 kDal) is freely filtered but reabsorbed by the 
proximal tubule. The amount of protein that comes 
out with urine reduces the levels of the total protein 
(TP) serum in patients with kidney failures.
UA is a compound of nitrogen produced from 
catabolism of purines either from diet or endoge-
nous nucleic acids (DNA deoxyribonucleic acid). It 
is largely excreted through the kidneys and slightly 
secreted through the gastrointestinal tract. The 
increasing levels of the UAs called hyperuricemia 
which can be caused by an excessive production or 
a decreasing excretion (such as in renal failure). The 
increasing level of UA in the urine is called uricosuria. 
The excretion of UA in the urine depends on the levels 
of UA in the blood, glomerular filtration, and tubular 
secretion of UA into the urine [13-16].
The results of the previous studies show that 30% 
of patients who were treated with gentamicin for more 
than 7 days indicated signs of nephrotoxicity. The 
gentamicin nephrotoxicity is one of the most common 
causes of the ARF [17]. Gentamicin belongs to a class 
of aminoglycosides and is an antibiotic commonly 
used to treat Gram-negative bacterial infections in 
humans and animals. It can cause nephrotoxicity and 
is a way to get an animal model of the ARF. The intra-
peritoneal (i.p.) administration of gentamicin leads to 
an increasing formation of superoxide to cause oxida-
tive stress and cellular damage in the proximal renal 
tubules of the kidney. If it is prolonged, it will cause 
an ARF [18].
Reactive oxygen species are potential mediators 
involved in the gentamicin induction of renal impair-
ment. The gentamicin leads to an increasing super-
oxide anions, peroxynitrite anions, and hydrogen 
peroxide from the renal cortex mitochondria. A raise 
of nitric oxide which occurs by the activation of the 
inducible nitric oxide synthase has proven to cause 
Figure-1: Kidney general structure. (a) The general structure of the kidney, (b) components of the nephron and ductus 
collectivus system [8].
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kidney disorders through several mechanisms. The 
gentamicin also produces interstitial edema and epi-
thelial necrosis [19].
Currently, there have been many attempts to find 
cheap and safe alternative medicine for the treatments 
of the kidney for instance using materials derived 
from plants. One of the plants whose benefits have 
been researched is pomegranate. It is a fruit which 
contains many phenolic compounds, namely, EA and 
punicalagin. In addition, the fruit is also composed of 
anthocyanin compounds such as prodelphinidin, del-
phinidin, sianidin, and pelargonidin [12]. However, 
until now the use of pomegranate to prevent the ARF 
has not been done. There are advantages of using 
herbal medicine such as it is easily produced, its appli-
cation is simple, and its cost is cheaper than the cost 
of pharmaceutical drugs. In general, the use of herbal 
medicine to cure diseases takes a long time, but the 
effect is to give protection, build and imply positively 
for other organs. This is different from consuming 
chemical drugs which have a faster-working process 
but damage both infected and normal organs [20].
Materials and Methods
Ethical approval
This study was duly approved by Institutional 
Animal Ethics Committee.
 Experimental design
This study is an experimental laboratory 
research. The research design is a randomized control 
group - only post-test design. The samples and the 
treatments were under scalable controlled conditions 
to keep the effects more valid. The production of ani-
mal models and its maintenance were performed in 
the Laboratory of Biochemistry, Faculty of Medicine, 
Universitas Airlangga, while the examination of 
various variables of the study was conducted at the 
Veterinary Teaching Hospital, Faculty of Veterinary 
Medicine, Universitas Airlangga. This study was con-
ducted after obtaining a certificate of conduct issued 
by a research ethics committee.
Research materials
The experimental units in this study were male 
strain Wistar white rats (Rattus norvegicus) which 
were obtained from the Animal Care Unit Experiment 
Universitas Gajah Mada, Yogyakarta. White rats were 
used because they were inexpensive, easily obtained, 
and maintained. The rats used in this study should 
have been male with the criteria of homogeneous 
samples, the age was 2.5 months old, the weight was 
between 150 and 200 g, and they were in good health 
condition, which was characterized by shiny fur sand 
eyes, and agile movement.
The tools used in this study were 1 cc syringes, a 
3-cc syringe and a 10-cc syringe, animal feed and drink 
containers, husks for the base of the cattle pen, a size 
8 feeding tube, a mortar, cotton, tweezers, and a scale. 
This study used standardized pomegranate extracts 
which contained 40% EA and pure EA produced by 
Xi’an Biof Bio-Technology Co., Ltd., gentamicin, 0.3% 
carboxy methylcellulose (CMC) Na, and 70% alcohol. 
The samples used were the weight and the 3 ml blood 
injected out of 32 male rats’ blood which was used for 
the examination of the TP content and the serum UA.
Research methods
The standardized pomegranate extracts given to 
the experimental animals were suspended with 0.3% 
CMC Na in the mortar to keep the homogeneity of the 
solvents [21]. The preparations were also made before 
be given to the experimental animals. The production 
of 0.3% CMC Na was done by sprinkling 0.3 g CMC 
Na in 100 ml of warm distilled water.
This study used 32 male rats Wistar aged 
2.5 months whose weight was between 150 and 200 g. 
Having adapted for 1 week, they were divided into 
four groups, namely, P0, P1, P2, and P3, in which 
each group was treated in eight cycles. The control 
group (P0) was given i.p. saline and 0.3% CMC Na 
orally, P1 was provided with 80 mg/kg bw/i.p. gen-
tamicin and 0.3% oral CMC Na, P2 was parted with 
80 mg/kg bw/i.p. gentamicin and 60 mg/kg bw EA 
in 0.3% CMC Na per oral, and P3 was given 80 mg/
kg bw/i.p. gentamicin and pomegranate extracts at a 
dose of 150 mg/kg bw in 0.3% Na CMC orally. The 
volume of saline and gentamicin was 0.4 cc, while 
the volume of the CMC Na solvent, EA and pome-
granate extracts was 2 cc. After 8 days of treatment, 
the weighing and the sampling of intracardiac blood 
was done. A dose of EA which was administered for 
8 days was 60 mg/kg bw/po/day. Based on the content 
of 40% EA found in the extracts, the fruit extract dose 
was 150 mg/kg/dd/po/day for 8 days [22]. Weighing 
had been done before performing blood sampling. The 
intracardiac blood samples were taken after the white 
e rats were anesthetized with ether incision in the tho-
racic region. Blood was collected as much as possible 
for an examination of the TP content and the serum 
UA.
The production and checking of the levels of 
serum TP were conducted by using the Biuret method. 
Based on the method, the principles of the protein 
determination levels in serum was the measurement of 
the purple complex light absorption of proteins to react-
ing with a biuret reagent. The complex was formed by 
Figure-2: Punica granatum L. [11].
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proteins with Cu2+ ions in a biuret reagent under alka-
line conditions. The higher the intensity of the absorbed 
light by the tool meant the higher the protein content 
was in the serum. The serum UA examination was done 
by the enzymatic method. The principle of the checking 
UA levels in enzymatic method was that uricase broke 
down the UA into allantoin and hydrogen peroxide. 
Then the presence of peroxidase, peroxide, N-ethyl-
N-(2-hidroxy-3-sulfopropy)-3-methylaniline (TOOS) 
and 4-aminophenazone formed the quinoneimine color. 
The intensity of the formed red color was proportional 
with the concentration of UA [23].
The results of the study were presented in a table 
of the average value and the standard deviation (SD). 
The treatment effects of the research variables were 
determined by performing a statistical analysis of 
variance (ANOVA). They were considered significant 
if F count > F table or p<0.05. Otherwise, the least 
significant difference test was proceeded.
Results
Weighing the white rats was firstly done to exam-
ine the variables of the study. The results are shown in 
Table-1.
The research variables are the levels of TP and 
UA from the blood serum which is taken from all of 
the rats after 8 days of treatment. The test results of the 
TP and UA in the Laboratory of Veterinary Teaching 
Hospital, Faculty of Veterinary Medicine, Universitas 
Airlangga to 32 rats which were divided into four 
treatments and eight cycles, namely P0 by administer-
ing saline and CMC Na as a control, P1 by adminis-
tering gentamicin and CMC Na, P2 by administering 
gentamicin, CMC Na and EA, and P3 by administer-
ing gentamicin, CMC Na and pomegranate extract, 
were processed by applying SPSS 17 for Windows by 
using ANOVA. The results of blood serum levels of 
TP and acid veins are shown in Table-2.
The average values and the SD of the TP lev-
els in groups P0, P1, P2, and P3 are 6.367±0.3615, 
0.3615±5.933, 5.917±0.5913, 5.683±0.3312, respec-
tively. Results of the statistical calculation of the total 
blood serum proteins are displayed in Table-3.
The results of the study using ANOVA for the 
four treatment groups display that the control group 
(P0) shows a significant difference from the treatment 
groups (P1, P2, and P3), and there is no significant dif-
ference among them. The average values of serum UA 
levels in groups P0, P1, P2, and P3 are 1.583±0.1472, 
1.450±0.6156, 1.8468±1.933, 1.300±0.1673, respec-
tively. The statistical calculation results of the serum 
UA levels in the blood are shown in Table-4.
The results reveal that the control group (P0) 
shows highly significant differences from the treat-
ment groups (P1, P2, and P3), but important distinc-
tions are found among the three groups while a highly 
important discrepancy is gathered between the treat-
ment groups P2 and P3.
Discussion
The study of blood serum TPs in white rats 
between the control group (P0) and the treatment 
groups (P1, P2, and P3) demonstrates significant dif-
ferences (p<0.05). P1 displays the highest levels of 
TPs because this group of white experimental rats with 
gentamicin was given 0.3% CMC Na. The decreasing 
levels of TP reflect a decline of the protein amount 
in the blood due to the gentamicin which has already 
penetrated into the kidney cells, especially the epithe-
lial cells of the proximal tubule. This causes malfunc-
tion, impaired metabolism of the membrane intracel-
lular, and damage of the epithelial cells of proximal 
tubular kidney which eventually lead to the ARF [24]. 
The damage of the glomerulus causes the glomeru-
lar selectivity walls fail to prevent proteins with large 
molecular weight to be out of the urine. It induces the 
leakage of plasma proteins which leads to urine and 
generates a condition of proteinuria [25].
The serum levels of TPs in white rats by the 
administration of gentamicin and EA (P2) suffers 
insignificant reduction than the treatment group P1. 
It can be noted that there are decreasing levels of 
the total blood serum proteins which are caused by 
the improved kidney cells. Meanwhile, the levels of 
TP blood serum of the white rats by the administra-
tion of gentamicin and pomegranate extracts in (P3) 
sustain inessential degradation than the treatment of 
group P2. P2 gets the treatment with the best results to 
reduce the levels of the TPs even though the outcome 
of the four treatment groups is still within the normal 
Table-1: Results of the white rats’ body weight measurement (g) before and after the treatments.
























1 170 195 160 190 175 200 200 200
2 190 200 150 160 170 220 195 220
3 170 190 170 160 155 130 180 180
4 160 190 180 150 170 190 190 205
5 170 175 170 190 190 220 200 240
6 155 175 200 170 150 160 200 220
7 200 225 175 170 180 210 150 150
8 185 215 150 175 200 190 180 180
Veterinary World, EISSN: 2231-0916 1273
Available at www.veterinaryworld.org/Vol.9/November-2016/17.pdf
values. The normal levels of the total blood serum 
proteins of male strain Wistar rats range from 5.0 to 
8.0 g/dL [25]. It shows that the combination of various 
active ingredients in pomegranates has a good effect 
because it can form a synergistic formulation [26].
Pomegranate (Punica granatum Linn) in 
group P3 contains polyphenols as the main ingredi-
ent and punicalagin and EA as the active ingredients. 
The punicalagin in pomegranates has an antioxidant 
activity up to 89%. It cannot be directly absorbed by 
the body because it has a lot of molecules which will 
undergo hydrolysis in the gut before the absorption. 
The hydrolysis in the intestine is done by the normal 
microbes in the gut to become EA which exists in the 
digestive tract [27]. The low concentrations of EA in 
the plasma are due to its low solubility in water. The 
insoluble EA metabolism is caused by microflora 
activities within the digestive tract. The existence of 
polyphenols in pomegranate extracts could increase 
the solubility of EA in the digestive tract. Moreover, 
polyphenols also have an ability to inhibit the metabo-
lism of EA done by intestinal microflora through their 
antibacterial activity [12].
The UA levels in the control group (P0) indicate 
a significant difference from the treatment groups 
(P1, P2, and P3). The results show that the treatment 
group P2 gives a better effect in decreasing the UA 
levels than the treatment group P3. This is because EA 
contains an antioxidant which decreases the levels of 
blood biochemistry toward normal values when there 
is a metabolic disorder in the blood [12]. The normal 
levels of serum UA blood of male rats strain Wistar 
range from 0.30 to 1.52 mg/dL [16].
Conclusion and Suggestion
Conclusion
The administration of pomegranate extracts as a 
nephrotoxicity treatment in white rats can maintain a 
normal weight of the rats, and the normal levels of TP 
and UA blood serum of white rats.
Suggestion
As this study is a preventive therapy, it is neces-
sary to conduct further researches on the effective dose 
of the pomegranate extracts as a curative therapy, the 
level of effectiveness and their long-term side effects.
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